Connect Biopharma Holdings (CNTB)
US Market

Connect Biopharma Holdings (CNTB) Financial Statements


Connect Biopharma Holdings Financial Overview

Connect Biopharma Holdings's market cap is currently ―. The company's EPS TTM is $-1.585; its P/E ratio is -0.58; Connect Biopharma Holdings is scheduled to report earnings on March 28, 2024, and the estimated EPS forecast is $-0.29. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Jun 22Dec 21Jun 21Dec 20
Income Statement-
Total Revenue-----
Gross Profit-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments¥ 550.27M¥ 1.28B¥ 1.71B¥ 2.03B¥ 1.02B
Total Assets¥ 174.01M¥ 1.58B¥ 1.86B¥ 2.17B¥ 1.08B
Total Debt¥ 3.00M¥ 3.77M¥ 793.00K¥ 1.10M¥ 913.00K
Net Debt¥ -547.28M¥ -1.28B¥ -1.71B¥ -2.02B¥ -1.02B
Total Liabilities¥ 16.52M¥ 145.65M¥ 119.83M¥ 91.11M¥ 2.11B
Stockholders Equity¥ 131.84M¥ 1.43B¥ 1.74B¥ 2.08B¥ -1.02B
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in CNY

Connect Biopharma Holdings Earnings and Revenue History

Connect Biopharma Holdings Debt to Assets

Connect Biopharma Holdings Cash Flow

Connect Biopharma Holdings Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis